Uncoupling protein 2 (UCP2) reprograms the TME from immunosuppressive to immunostimulatory by increasing CXCL10 production, attracting T cells to the tumor, and normalizing tumor vasculature, which further improves T cell infiltration [95]. The gene discussed is UCP2; the disease is neoplasm.